Disruption of DDX53 coding sequence has limited impact on iPSC-derived human NGN2 neurons
The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends b...
Saved in:
Published in | BMC medical genomics Vol. 16; no. 1; pp. 5 - 12 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
12.01.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons.
We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed.
Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed.
DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. |
---|---|
AbstractList | The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons. We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed. Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed. DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons. We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed. Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed. DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. Background The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons. Methods We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed. Results Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed. Conclusion DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. Keywords: ASD, iPSCs, DDX53, PTCHD1-AS, CRISPR, NGN2 Abstract Background The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons. Methods We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed. Results Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed. Conclusion DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons.BACKGROUNDThe X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long non-coding RNA (PTCHD1-AS)/DEAD-box helicase 53 (DDX53) have ASD, or a sub-clinical form called Broader Autism Phenotype. If the deletion extends beyond PTCHD1-AS/DDX53 to the next gene, PTCHD1, which is protein-coding, the individuals typically have ASD and intellectual disability (ID). Three male siblings with a 90 kb deletion that affects only PTCHD1-AS (and not including DDX53) have ASD. We performed a functional analysis of DDX53 to examine its role in NGN2 neurons.We used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed.METHODSWe used the clustered regularly interspaced short palindromic repeats (CRISPR) gene editing strategy to knock out DDX53 protein by inserting 3 termination codons (3TCs) into two different induced pluripotent stem cell (iPSC) lines. DDX53 CRISPR-edited iPSCs were differentiated into cortical excitatory neurons by Neurogenin 2 (NGN-2) directed differentiation. The functional differences of DDX53-3TC neurons compared to isogenic control neurons with molecular and electrophysiological approaches were assessed.Isogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed.RESULTSIsogenic iPSC-derived control neurons exhibited low levels of DDX53 transcripts. Transcriptional analysis revealed the generation of excitatory cortical neurons and DDX53 protein was not detected in iPSC-derived control neurons by western blot. Control lines and DDX53-3TC neurons were active in the multi-electrode array, but no overt electrophysiological phenotype in either isogenic line was observed.DDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type.CONCLUSIONDDX53-3TC mutation does not alter NGN2 neuronal function in these experiments, suggesting that synaptic deficits causing ASD are unlikely in this cell type. |
ArticleNumber | 5 |
Audience | Academic |
Author | Piekna, Alina Rodrigues, Deivid C. Shum, Carole Ross, P. Joel Thiruvahindrapuram, Bhooma Wei, Wei Howe, Jennifer L. Bradley, Clarrisa A. Lamoureux, Sylvia Faheem, Muhammad Zarrei, Mehdi Scherer, Stephen W. Alexandrova, Roumiana Pellecchia, Giovanna Ellis, James Deneault, Eric |
Author_xml | – sequence: 1 givenname: Muhammad surname: Faheem fullname: Faheem, Muhammad – sequence: 2 givenname: Eric surname: Deneault fullname: Deneault, Eric – sequence: 3 givenname: Roumiana surname: Alexandrova fullname: Alexandrova, Roumiana – sequence: 4 givenname: Deivid C. surname: Rodrigues fullname: Rodrigues, Deivid C. – sequence: 5 givenname: Giovanna surname: Pellecchia fullname: Pellecchia, Giovanna – sequence: 6 givenname: Carole surname: Shum fullname: Shum, Carole – sequence: 7 givenname: Mehdi surname: Zarrei fullname: Zarrei, Mehdi – sequence: 8 givenname: Alina surname: Piekna fullname: Piekna, Alina – sequence: 9 givenname: Wei surname: Wei fullname: Wei, Wei – sequence: 10 givenname: Jennifer L. surname: Howe fullname: Howe, Jennifer L. – sequence: 11 givenname: Bhooma surname: Thiruvahindrapuram fullname: Thiruvahindrapuram, Bhooma – sequence: 12 givenname: Sylvia surname: Lamoureux fullname: Lamoureux, Sylvia – sequence: 13 givenname: P. Joel surname: Ross fullname: Ross, P. Joel – sequence: 14 givenname: Clarrisa A. surname: Bradley fullname: Bradley, Clarrisa A. – sequence: 15 givenname: James surname: Ellis fullname: Ellis, James – sequence: 16 givenname: Stephen W. surname: Scherer fullname: Scherer, Stephen W. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36635662$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk9rFDEYxoNUbLv6BTzIgBc9TM3_TC5C2dW6UKpYBT2FbJLZTZlJ1mSmtN_ebKeVrojJIeHN8_zyJjzH4CDE4AB4ieAJQg1_lxGWGNYQ4xoiillNnoAjJBirGyHpwaP9ITjO-QpCDplEz8Ah4ZwwzvER-LnwOY3bwcdQxbZaLH4wUplofVhX2f0aXTCu2uhcdb73g7OV77faDFWR-y-X89q65K9LeTP2OlQXZxe4Cm5MMeTn4Gmru-xe3K8z8P3jh2_zT_X557Pl_PS8NozLoW6xlpZoLY3FUBAp7WpFW97oxjUSQQ01XVG2EoS71nEBjaS4DG4wJVAgS2ZgOXFt1Fdqm3yv062K2qu7QkxrpdPgTeeUtsxC3FgLGaGE0MZpQZgo17aYwrYprPcTazuuemeNC0PS3R50_yT4jVrHayUbIqSgBfDmHpBi-bw8qN5n47pOBxfHrLDgTAhGSgMz8HqSrnVpzYc2FqLZydWpIARRRNgOePIPVZnW9d6UPLS-1PcMb_cMRTO4m2Gtx5zV8vLrvvbV4-f-eedDPIqgmQQmxZyTa5Xxg96FpXThO4Wg2iVRTUlUJYnqLomKFCv-y_pA_4_pNxip3Fc |
CitedBy_id | crossref_primary_10_1038_s41380_023_02377_5 crossref_primary_10_1038_s41398_024_03058_9 crossref_primary_10_3390_cimb46050255 crossref_primary_10_1016_j_ajhg_2024_11_003 crossref_primary_10_1007_s00109_024_02454_4 |
Cites_doi | 10.1038/s41467-019-13380-2 10.1038/nature12618 10.1016/j.cell.2007.11.019 10.1038/nn.4524 10.1038/nmeth.1325 10.31887/DCNS.2017.19.4/sscherer 10.1126/scitranslmed.3001267 10.1016/j.cell.2022.10.009 10.1016/j.gde.2012.03.002 10.1038/nature09146 10.1016/j.neuron.2013.05.029 10.1016/j.ajhg.2014.03.018 10.3389/fncel.2014.00109 10.1038/mp.2014.141 10.1016/j.stemcr.2018.10.003 10.1016/j.biopsych.2019.07.014 10.1038/s41576-020-0231-2 10.1126/science.aaf2669 10.7554/eLife.40092 10.1016/j.ajhg.2007.12.009 10.3390/genes13030527 10.1093/cercor/bhp187 10.1111/cge.12482 10.1038/s41593-019-0365-8 |
ContentType | Journal Article |
Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. The Author(s) 2023 |
Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: The Author(s) 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 7X8 5PM DOA |
DOI | 10.1186/s12920-022-01425-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Science in Context MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1755-8794 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_ad5d028dd05343348ea7357073f240f8 PMC9837974 A733141354 36635662 10_1186_s12920_022_01425_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GrantInformation_xml | – fundername: CIHR – fundername: ; |
GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7X8 PJZUB PPXIY PQGLB 5PM PUEGO |
ID | FETCH-LOGICAL-c569t-f2a9d3aa9cd207399dbb4f68a8e8910a0a4b45b736efe670c9422226c243071d3 |
IEDL.DBID | M48 |
ISSN | 1755-8794 |
IngestDate | Wed Aug 27 01:23:49 EDT 2025 Thu Aug 21 18:38:40 EDT 2025 Mon Jul 21 11:34:57 EDT 2025 Tue Jun 17 20:50:45 EDT 2025 Tue Jun 10 20:23:22 EDT 2025 Fri Jun 27 06:02:36 EDT 2025 Thu Jan 02 22:52:47 EST 2025 Thu Apr 24 23:02:06 EDT 2025 Tue Jul 01 02:55:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | PTCHD1-AS DDX53 CRISPR iPSCs NGN2 ASD |
Language | English |
License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c569t-f2a9d3aa9cd207399dbb4f68a8e8910a0a4b45b736efe670c9422226c243071d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12920-022-01425-3 |
PMID | 36635662 |
PQID | 2765775305 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ad5d028dd05343348ea7357073f240f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9837974 proquest_miscellaneous_2765775305 gale_infotracmisc_A733141354 gale_infotracacademiconefile_A733141354 gale_incontextgauss_ISR_A733141354 pubmed_primary_36635662 crossref_citationtrail_10_1186_s12920_022_01425_3 crossref_primary_10_1186_s12920_022_01425_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-01-12 |
PublicationDateYYYYMMDD | 2023-01-12 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-12 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC medical genomics |
PublicationTitleAlternate | BMC Med Genomics |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | A Noor (1425_CR4) 2010; 2 L D'Abate (1425_CR22) 2019; 10 RK Yuen (1425_CR18) 2017; 20 A Shcheglovitov (1425_CR11) 2013; 503 E Deneault (1425_CR14) 2018; 11 K Takahashi (1425_CR8) 2007; 131 CP Schaaf (1425_CR7) 2020; 21 SF Pastore (1425_CR23) 2022; 13 F Yi (1425_CR13) 2016; 352 D Pinto (1425_CR3) 2014; 94 A Hotta (1425_CR17) 2009; 6 B Devlin (1425_CR1) 2012; 22 Y Zhang (1425_CR19) 2013; 78 CR Marshall (1425_CR16) 2008; 82 L Roybon (1425_CR21) 2010; 20 E Deneault (1425_CR20) 2019; 12 K Griesi-Oliveira (1425_CR12) 2015; 20 BA Fernandez (1425_CR2) 2017; 19 DS Kim (1425_CR9) 2014; 8 D Pinto (1425_CR5) 2010; 466 PJ Ross (1425_CR10) 2020; 87 K Zaslavsky (1425_CR15) 2019; 22 B Trost (1425_CR24) 2022; 185 A Chaudhry (1425_CR6) 2015; 88 |
References_xml | – volume: 10 start-page: 5519 issue: 1 year: 2019 ident: 1425_CR22 publication-title: Nat Commun doi: 10.1038/s41467-019-13380-2 – volume: 503 start-page: 267 issue: 7475 year: 2013 ident: 1425_CR11 publication-title: Nature doi: 10.1038/nature12618 – volume: 131 start-page: 861 issue: 5 year: 2007 ident: 1425_CR8 publication-title: Cell doi: 10.1016/j.cell.2007.11.019 – volume: 20 start-page: 602 year: 2017 ident: 1425_CR18 publication-title: Nat Neurosci doi: 10.1038/nn.4524 – volume: 6 start-page: 370 year: 2009 ident: 1425_CR17 publication-title: Nat Methods doi: 10.1038/nmeth.1325 – volume: 19 start-page: 353 issue: 4 year: 2017 ident: 1425_CR2 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2017.19.4/sscherer – volume: 2 start-page: 49ra68 issue: 49 year: 2010 ident: 1425_CR4 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3001267 – volume: 185 start-page: 4409 year: 2022 ident: 1425_CR24 publication-title: Cell doi: 10.1016/j.cell.2022.10.009 – volume: 22 start-page: 229 issue: 3 year: 2012 ident: 1425_CR1 publication-title: Curr Opin Genet Dev doi: 10.1016/j.gde.2012.03.002 – volume: 466 start-page: 368 issue: 7304 year: 2010 ident: 1425_CR5 publication-title: Nature doi: 10.1038/nature09146 – volume: 78 start-page: 785 issue: 5 year: 2013 ident: 1425_CR19 publication-title: Neuron doi: 10.1016/j.neuron.2013.05.029 – volume: 94 start-page: 677 issue: 5 year: 2014 ident: 1425_CR3 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2014.03.018 – volume: 8 start-page: 109 year: 2014 ident: 1425_CR9 publication-title: Front Cell Neurosci doi: 10.3389/fncel.2014.00109 – volume: 20 start-page: 1350 issue: 11 year: 2015 ident: 1425_CR12 publication-title: Mol Psychiatry doi: 10.1038/mp.2014.141 – volume: 11 start-page: 1211 issue: 5 year: 2018 ident: 1425_CR14 publication-title: Stem Cell Reports doi: 10.1016/j.stemcr.2018.10.003 – volume: 87 start-page: 139 issue: 2 year: 2020 ident: 1425_CR10 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2019.07.014 – volume: 21 start-page: 367 issue: 6 year: 2020 ident: 1425_CR7 publication-title: Nat Rev Genet doi: 10.1038/s41576-020-0231-2 – volume: 352 start-page: aaf2669 issue: 6286 year: 2016 ident: 1425_CR13 publication-title: Science doi: 10.1126/science.aaf2669 – volume: 12 start-page: e40092 issue: 8 year: 2019 ident: 1425_CR20 publication-title: Elife doi: 10.7554/eLife.40092 – volume: 82 start-page: 477 issue: 2 year: 2008 ident: 1425_CR16 publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2007.12.009 – volume: 13 start-page: 527 issue: 3 year: 2022 ident: 1425_CR23 publication-title: Genes doi: 10.3390/genes13030527 – volume: 20 start-page: 1234 issue: 5 year: 2010 ident: 1425_CR21 publication-title: Cereb Cortex doi: 10.1093/cercor/bhp187 – volume: 88 start-page: 224 issue: 3 year: 2015 ident: 1425_CR6 publication-title: Clin Genet doi: 10.1111/cge.12482 – volume: 22 start-page: 556 issue: 4 year: 2019 ident: 1425_CR15 publication-title: Nat Neurosci doi: 10.1038/s41593-019-0365-8 |
SSID | ssj0060591 |
Score | 2.3480468 |
Snippet | The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense long... Background The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1 antisense... Abstract Background The X-linked PTCHD1 locus is strongly associated with autism spectrum disorder (ASD). Males who carry chromosome microdeletions of PTCHD1... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 5 |
SubjectTerms | Analysis ASD Autism Autism Spectrum Disorder - genetics Care and treatment CRISPR DDX53 DEAD-box RNA Helicases - genetics Diagnosis Humans Induced Pluripotent Stem Cells - metabolism iPSCs Male Methods Mutation Neurons Neurons - metabolism Neurophysiology NGN2 PTCHD1-AS Stem cells |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gIIOQOKCoiV-Jj6VLKUisEKXScrIcP9qVqgQ1u_x-ZpxktRESXLjGEyWefPbMODPfEPImajArzhW5LbAkxzc2r3VkOY8FsrMXUvqU5btUZxfi80qu9lp9YU7YQA88KO7IeunBBnoPaBFYNhpsxWUFyIxgjGIq8wWbNwVTwx4Mz9DlVCJTq6O-xKZMOWauQ0jAZM5nZiix9f-5J-8ZpXnC5J4FOr1H7o6uIz0eXvk-uRXaB-T2l_Hn-EPyY7Hub7ZpC6BdpIvFSnLqOjROdMqYple2p9dDURMdKiQpiK-_np_kHsD4Cy6ntn10-XHJaGK7bPtH5OL0w_eTs3zsnJA7qfQmj8xqz63VzjP8Fad904ioaluHGvwDW1jRCNlUXIUYVFU4jSdBTDkmYM2Xnj8mB23XhqeESquiUza4ApQvPLO-EcyHRikRtKubjJSTIo0bacWxu8W1SeFFrcygfAPKN0n5hmfk3e6enwOpxl-l3-P32UkiIXa6ADAxI0zMv2CSkdf4dQ1SXrSYU3Npt31vPp1_M8fYthJsuRQZeTsKxQ7m4OxYogCaQJasmeThTBLWpJsNv5pAZHAIE9na0G17wyolKwgRC5mRJwOodhPj6P0pxTJSzeA2m_l8pF1fJUpwXfMKIsNn_0NVz8kdBp4cnjOV7JAcbG624QV4XpvmZVpkvwHvriXo priority: 102 providerName: Directory of Open Access Journals |
Title | Disruption of DDX53 coding sequence has limited impact on iPSC-derived human NGN2 neurons |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36635662 https://www.proquest.com/docview/2765775305 https://pubmed.ncbi.nlm.nih.gov/PMC9837974 https://doaj.org/article/ad5d028dd05343348ea7357073f240f8 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBf9gNKXse9564I2BnsY3mx92X4YI23adYGG0iyQPQlZstpAsLc4Gdt_v5Nsh5qVPezJIJ0w0t3pTtLd7xB6YzMwK1pHoYpcSo7JVZhmloTURg6dPeLc-CjfiTifsfGcz3dQV-6oXcD6zqOdqyc1Wy3f__rx-xMo_Eev8Kn4UMeu5FLo4tLB4Sc8pLtoHyxT4hT1gm1fFeDPWdwlztw57hAdUGeChSA9O-Xh_P_etG9ZrX5E5S0TdXYf3Wt9SzxshOEB2inKh-jgon09f4S-jRb1auP3CFxZPBrNOcW6ctYLdyHV-EbVeNlkPeEmhRID-eJyehIakNaf0Ozr-uHJ5wnBHg6zrB-j2dnp15PzsC2tEGousnVoicoMVSrThri3uszkObMiVWmRggOhIsVyxvOEisIWIol05q6KiNCEwaYQG_oE7ZVVWTxDmCthtVCFjihlzBBlckZMkQvBikyneYDibiGlbnHHXfmLpfTnj1TIhg8S-CA9HyQN0LvtmO8N6sY_qY8df7aUDjHbN1Sra9kqoFSGG_CljIFdh7n040IllCcweQtOjU0D9NpxVzpMjNIF3VyrTV3LL9MrOXR1LcHYcxagty2RrWAOWrU5DLASDkarR3nUowSl1b3uV50QSdflIt3KotrUkiSCJ3CGjHiAnjZCtZ1YJ5sBSnri1pt5v6dc3HjM8CylCRwdn__3yBfokIB_526fYnKE9tarTfES_LF1PkC7yTwZoP3hcDwdw_f4dHJ5NfC3GwOvgH8ALwEz_g |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disruption+of+DDX53+coding+sequence+has+limited+impact+on+iPSC-derived+human+NGN2+neurons&rft.jtitle=BMC+medical+genomics&rft.au=Faheem%2C+Muhammad&rft.au=Deneault%2C+Eric&rft.au=Alexandrova%2C+Roumiana&rft.au=Rodrigues%2C+Deivid+C.&rft.date=2023-01-12&rft.pub=BioMed+Central&rft.eissn=1755-8794&rft.volume=16&rft_id=info:doi/10.1186%2Fs12920-022-01425-3&rft_id=info%3Apmid%2F36635662&rft.externalDocID=PMC9837974 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-8794&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-8794&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-8794&client=summon |